Girmay Desalegn
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 13, 2025
A broad spectrum Shigella vaccine based on VirG53-353 multiepitope region produced in a cell-free system.Girmay Desalegn, Charlotte Abrahamson, K Ross Turbyfill
|Feb 13, 2024
Prevalence and Antimicrobial Resistance of Campylobacter Species and Associated Factors Among Under-Five Children with Diarrhea at Randomly Selected Public Health Facilities in Mekelle, Tigray, Ethiopia.Kebede Araya Abay, Girmay Desalegn, Yemane Weldu
|Jan 03, 2024
Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate.Girmay Desalegn, Chitradevi S Tamilselvi, Jose M Lemme-Dumit
|Apr 05, 2023
A Novel Shigella O-Polysaccharide-IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Shigella Serotypes.Girmay Desalegn, Neeraj Kapoor, Lucy Pill-Pepe
|Oct 12, 2019
Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.Girmay Desalegn, Aster Tsegaye, Dawit Gebreegziabiher
|Jul 21, 2019
Inflammation triggers immediate rather than progressive changes in monocyte differentiation in the small intestine.Girmay Desalegn, Oliver Pabst
Pageof 1
